Commentary: Objective aids for the assessment of ADHD - further clarification of what FDA approval for marketing means and why NEBA might help clinicians. A response to Arns et al. (2016)

JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

卷 57, 期 6, 页码 770-771

WILEY

-

Psychology, Developmental Psychiatry Psychology

1. Pfizer
2. Ironshore Pharmaceuticals
3. Shire